Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TARS Tarsus Pharmaceuticals, Inc.

交易中 12-17 11:30:07 EST

78.83

+0.55

+0.70%

最高79.54	最低78.01	成交量6.56万
今开78.42	昨收78.28	日振幅1.95%
总市值33.46亿	流通市值23.92亿	总股本4,245万
成交额516.59万	换手率0.22%	流通股本3,035万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TARS","market":"US","secType":"STK","nameCN":"Tarsus Pharmaceuticals, Inc.","latestPrice":78.825,"timestamp":1765989003703,"preClose":78.28,"halted":0,"volume":65561,"delay":0,"floatShares":30351553,"shares":42449105,"eps":-1.992481,"marketStatus":"交易中","change":0.545,"latestTime":"12-17 11:30:07 EST","open":78.42,"high":79.54,"low":78.01,"amount":5165913.08672,"amplitude":0.019545,"askPrice":79.12,"askSize":70,"bidPrice":78.84,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-1.992481,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766005200000},"marketStatusCode":2,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":78.28,"preHourTrading":{"tag":"盘前","latestPrice":77.51,"preClose":78.28,"latestTime":"09:24 EST","volume":19,"amount":1472.69,"timestamp":1765981449172},"postHourTrading":{"tag":"盘后","latestPrice":78.28,"preClose":78.28,"latestTime":"18:33 EST","volume":132626,"amount":10381963.31,"timestamp":1765927984117},"volumeRatio":0.386341,"impliedVol":0.6678,"impliedVolPercentile":0.756},"requestUrl":"/m/hq/s/TARS/wiki","defaultTab":"wiki","newsList":[{"id":"2582435275","title":"Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨5.19%报71.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582435275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582435275?lang=zh_cn&edition=full","pubTime":"2025-11-11 00:01","pubTimestamp":1762790509,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日00时01分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.19%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Galecto, Inc.、Cogent Biosciences, Inc.、Pluri Inc.涨幅较大，Galecto, Inc.、Inflarx N.V.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为2080.18%、98.51%、91.16%，振幅较大的相关个股有Galecto, Inc.、Inflarx N.V.、Briacell Therapeutics Corp C/Wts ，振幅分别为169.49%、35.77%、31.62%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111000149976091fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111000149976091fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2582135276","title":"Tarsus Pharmaceuticals, Inc.2025财年第三财季实现净利润-12.59百万美元，同比增加46.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582135276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582135276?lang=zh_cn&edition=full","pubTime":"2025-11-11 00:00","pubTimestamp":1762790434,"startTime":"0","endTime":"0","summary":"11月11日，Tarsus Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第三财季净利润为-12.59百万美元，同比增加46.24%；其中营业收入为1.19亿美元，同比增加147.30%，每股基本收益为-0.30美元。从资产负债表来看，Tarsus Pharmaceuticals, Inc.总负债1.99亿美元，其中短期债务80000.00美元，资产负债比为2.69，流动比率为4.30。机构评级：截至2025年11月11日，当前有8家机构对Tarsus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为84.38美元，其中最低目标价为51.00美元，最高目标价为95.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111000047a497ab1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111000047a497ab1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS"],"gpt_icon":0},{"id":"2567190639","title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","url":"https://stock-news.laohu8.com/highlight/detail?id=2567190639","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567190639?lang=zh_cn&edition=full","pubTime":"2025-09-13 06:38","pubTimestamp":1757716705,"startTime":"0","endTime":"0","summary":"研发新冠疫苗的BioNTech盘中跌超10%、莫德纳跌超7%、Novavax跌超4%。投资者担心，如果特朗普政府进一步收紧疫苗接种政策，可能对疫苗制造商的业务造成重大冲击，特别是对莫德纳这类高度依赖新冠疫苗收入的公司。更新中","market":"us","thumbnail":"https://static.tigerbbs.com/632b4e916ff966270173f4303843021f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/632b4e916ff966270173f4303843021f"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3755508","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"ae8bc75ba4d1918dcafc0476d86c6d53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3755508","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["NVS","ABUS","TVTX","PGEN","STRO","TARS","KALV","NVAX","PSNL","BK4009","AZN","MRNA","ARCT","SRPT","BNTX","MRK","PFE","BMY","TRVI"],"gpt_icon":1},{"id":"2566661785","title":"计算机行业周报：清华等机构开源强化学习框架RLINF 字节发布原生GUI智能体UI-TARS-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2566661785","media":"华鑫证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566661785?lang=zh_cn&edition=full","pubTime":"2025-09-09 00:00","pubTimestamp":1757347200,"startTime":"0","endTime":"0","summary":"算力： 算力租赁价格平稳，清华等机构开源强化学习框架RLinf9 月1 日，清华大学、北京中关村学院与无问芯穹等机构联合开源了全球首个面向具身智能的大规模强化学习框架RLinf。投资建议2025 年9 月4 日，博通发布2025 财年第三财季财报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909142634a4bd67fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909142634a4bd67fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2250418816.HKD","LU0868494617.USD","LU0354030511.USD","LU0096364046.USD","BK4515","BK4533","SG9999015952.SGD","LU1670710588.SGD","LU2168564149.EUR","LU1366333091.USD","LU2237438978.USD","LU0642271901.SGD","SG9999015978.USD","LU0323591593.USD","LU1804176565.USD","LU1992135472.HKD","LU2322448957.HKD","LU0069063385.USD","LU0912757837.SGD","LU1642822529.SGD","LU0784384876.USD","IE00BMPRXN33.USD","LU1868837136.USD","LU0640476718.USD","LU0345769128.USD","LU0353189680.USD","LU0949170772.SGD","IE00BKDWB100.SGD","IE0005OL40V9.USD","SG9999002232.USD","LU0348723411.USD","AVGO","LU0157215616.USD","GO","LU0965509101.SGD","LU1037948897.HKD","LU0096362180.USD","LU2279689827.SGD","LU2125154935.USD","IE00BYV24P56.USD","LU2420271590.USD","LU0274383776.USD","LU1145028129.USD","LU1242518857.USD","LU1316542783.SGD","TARS","LU1551013342.USD","UI","LU0256863902.USD","LU0154236417.USD","SG9999001424.SGD"],"gpt_icon":1},{"id":"2558691226","title":"Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨5.02%报50.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558691226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558691226?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:52","pubTimestamp":1754923979,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时52分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.02%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Entero Therapeutics Inc.、Equillium, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5166.76%、415.13%、158.62%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为84.05%、74.27%、54.40%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122525994dcdf26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122525994dcdf26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"1105664956","title":"异动解读 | 塔苏斯制药盘中大涨12.20%，Q2营收暴增151.5%超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1105664956","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105664956?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:00","pubTimestamp":1754575217,"startTime":"0","endTime":"0","summary":"塔苏斯制药今日盘中大涨12.20%，延续了盘前和昨日夜盘的强劲涨势。这波显著涨幅主要源于公司最新公布的第二季度财报远超市场预期。根据财报显示，塔苏斯制药第二季度营收同比大幅增长151.5%，达到1.0266亿美元，远超分析师预期的9568万美元。华尔街分析师对塔苏斯制药的前景保持乐观态度。这些积极的分析师评级和远高于当前价格的目标价，进一步增强了投资者对塔苏斯制药未来发展的信心，推动股价强劲上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TARS"],"gpt_icon":1},{"id":"2557569904","title":"Tarsus Pharmaceuticals, Inc.盘中异动 大幅拉升12.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557569904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557569904?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:32","pubTimestamp":1754573554,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时32分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价快速上涨12.20%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Palisade Bio, Inc.、Xeris制药、Sarepta Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Processa Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为493.70%、62.82%、21.56%，振幅较大的相关个股有Lantern Pharma Inc.、Palisade Bio, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为101.17%、39.00%、26.09%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213234a47b250d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213234a47b250d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"1191560474","title":"异动解读 | 美股异动：Tarsus制药盘前大涨7.44%，Q2营收超预期暴增151.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191560474","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191560474?lang=zh_cn&edition=full","pubTime":"2025-08-07 19:40","pubTimestamp":1754566854,"startTime":"0","endTime":"0","summary":"Tarsus制药盘前股价大涨7.44%，延续了周三夜盘9.44%的涨幅。根据Tarsus制药发布的财报显示，截至6月30日的第二季度，公司营收同比大幅增长151.5%，达到1.0266亿美元，显著超过分析师预期的9568万美元。华尔街分析师对Tarsus制药的前景保持乐观态度。分析师给出的12个月目标价中位数为72.00美元，较当前股价有约42.8%的上涨空间。这些积极的分析师评级和远高于当前价格的目标价，进一步增强了投资者对Tarsus制药未来发展的信心，推动股价强劲上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TARS"],"gpt_icon":1},{"id":"1162760902","title":"异动解读 | 塔苏斯制药Q2营收超预期，股价盘前大涨7.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162760902","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162760902?lang=zh_cn&edition=full","pubTime":"2025-08-07 19:40","pubTimestamp":1754566843,"startTime":"0","endTime":"0","summary":"塔苏斯制药今日盘前大涨7.44%，引发市场广泛关注。这一显著涨幅主要源于公司最新公布的第二季度财报超出市场预期。根据财报显示，塔苏斯制药第二季度营收同比大幅增长151.5%，达到1.0266亿美元，远超分析师预期的9568万美元。尽管季度业绩仍处于亏损状态，但华尔街分析师对塔苏斯制药的前景保持乐观。分析师给出的12个月目标价中位数为72.00美元，较上一交易日收盘价41.15美元高出约42.8%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TARS"],"gpt_icon":1},{"id":"1187413363","title":"异动解读 | Tarsus制药夜盘大涨9.44%，Q2营收超预期增长151.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187413363","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187413363?lang=zh_cn&edition=full","pubTime":"2025-08-07 11:37","pubTimestamp":1754537861,"startTime":"0","endTime":"0","summary":"周三夜盘，Tarsus制药股价大涨9.44%，引发市场广泛关注。根据财报显示，Tarsus制药第二季度营收同比大幅增长151.5%，达到1.0266亿美元，超过分析师预期的9568万美元。尽管季度业绩仍处于亏损状态，但华尔街分析师对Tarsus制药的前景保持乐观。分析师给出的12个月目标价中位数为72.00美元，较上一交易日收盘价41.15美元高出约42.8%。这些积极的分析师评级和远高于当前价格的目标价可能是推动股价大涨的另一个因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TARS"],"gpt_icon":1},{"id":"2556843938","title":"Tarsus Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.00%报40.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556843938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556843938?lang=zh_cn&edition=full","pubTime":"2025-08-02 02:23","pubTimestamp":1754072638,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日02时23分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.00%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Equillium, Inc.、Sensei Biotherapeutics, Inc.、4D Molecular Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为1746.24%、287.42%、207.30%，振幅较大的相关个股有Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天境生物，振幅分别为135.45%、72.18%、58.71%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802022359972d75d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802022359972d75d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2555010065","title":"Tarsus Pharmaceuticals, Inc.盘中异动 下午盘大幅下挫5.15%报39.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555010065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555010065?lang=zh_cn&edition=full","pubTime":"2025-07-30 02:39","pubTimestamp":1753814383,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日02时39分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.15%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Salarius Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Moleculin Biotech, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5548.86%、4009.02%、1808.20%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为176.76%、111.54%、75.60%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300239439725f905&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300239439725f905&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2551187243","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187243?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:40","pubTimestamp":1752504001,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时40分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.19%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。消息层面，截至22时40分，《美银证券维持Tarsus Pharmaceuticals买入评级，下调目标价至68美元》资讯为影响Tarsus Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071422400295423b4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071422400295423b4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2551192617","title":"IPO周报｜本周2只新股申购，国家电网“小伙伴”来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2551192617","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551192617?lang=zh_cn&edition=full","pubTime":"2025-07-14 07:35","pubTimestamp":1752449700,"startTime":"0","endTime":"0","summary":"本周新股申购迎来国家电网“小伙伴”。澎湃新闻根据Wind及公开信息梳理统计，本周有2只新股安排申购，分别为山东山大电力技术股份有限公司、技源集团股份有限公司。上周共有2只新股上市，分别为同宇新材料（广东）股份有限公司、北京屹唐半导体科技股份有限公司。本周，上交所将继续开审。上周，港股共有3家企业递交招股书。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-07-14/doc-inffkwqx4767023.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-07-14/doc-inffkwqx4767023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603262","TARS","301609","BK4007","FFR"],"gpt_icon":0},{"id":"2549514481","title":"它石智航完成1.22亿美元天使+轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2549514481","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549514481?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:23","pubTimestamp":1751962980,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　7月8日，它石智航宣布完成1.22亿美元天使+轮融资。　　它石智航正式成立于2025年2月5日，是一家由 AI 驱动的具身智能技术公司。投资者据此操作，风险自担。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2025-07-08/doc-infetywk3406460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SINA","BK4007","TARS"],"gpt_icon":0},{"id":"2518278443","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518278443?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:01","pubTimestamp":1741615315,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时01分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.19%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为666.08%、322.06%、92.32%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022015598a2a50d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022015598a2a50d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2517114703","title":"杰富瑞投资银行：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由54.00美元调整至58.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517114703","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517114703?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:02","pubTimestamp":1741302171,"startTime":"0","endTime":"0","summary":"杰富瑞投资银行：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由54.00美元调整至58.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070248578853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TARS"],"gpt_icon":0},{"id":"2517600796","title":"Tarsus Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517600796?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:02","pubTimestamp":1741114942,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时02分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.08%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305030223963984dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305030223963984dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2516552737","title":"Tarsus Pharmaceuticals, Inc.2024财年实现净利润-1.16亿美元，同比增加14.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552737?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:00","pubTimestamp":1740844851,"startTime":"0","endTime":"0","summary":"3月2日，Tarsus Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.16亿美元，同比增加14.71%；其中营业收入为1.83亿美元，同比增加948.71%，每股基本收益为-3.07美元。机构评级：截至2025年3月2日，当前有9家机构对Tarsus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为67.33美元，其中最低目标价为45.00美元，最高目标价为85.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104abe2c56e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104abe2c56e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS"],"gpt_icon":0},{"id":"2514685738","title":"Guggenheim：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由75.00美元调整至78.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685738","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514685738?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:11","pubTimestamp":1740586273,"startTime":"0","endTime":"0","summary":"Guggenheim：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由75.00美元调整至78.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27001148413689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TARS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tarsusrx.com","stockEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":0.0735},{"period":"3month","weight":0.5144},{"period":"6month","weight":0.906},{"period":"1year","weight":0.5132},{"period":"ytd","weight":0.4138}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tarsus Pharmaceuticals, Inc.是根据特拉华州法律于2016年11月成立的公司。该公司是一家处于临床后期的生物制药公司，致力于治疗性候选药物的开发和商业化，以解决最初存在眼科疾病的巨大市场机遇有限的治疗选择。该公司的主要产品候选产品TP-03是2b/3期的新型疗法，目前正在开发中，用于治疗由蠕形螨引起的眼睑炎，这被称为蠕形螨眼。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.039062},{"month":2,"riseRate":0.2,"avgChangeRate":0.010659},{"month":3,"riseRate":0.2,"avgChangeRate":-0.047875},{"month":4,"riseRate":0.6,"avgChangeRate":0.02077},{"month":5,"riseRate":0.6,"avgChangeRate":-0.033136},{"month":6,"riseRate":0.4,"avgChangeRate":-0.04436},{"month":7,"riseRate":0.4,"avgChangeRate":-0.024485},{"month":8,"riseRate":0.8,"avgChangeRate":0.123751},{"month":9,"riseRate":0.8,"avgChangeRate":0.033781},{"month":10,"riseRate":0.8,"avgChangeRate":0.135195},{"month":11,"riseRate":0.666667,"avgChangeRate":0.092511},{"month":12,"riseRate":0.5,"avgChangeRate":0.114607}],"exchange":"NASDAQ","name":"Tarsus Pharmaceuticals, Inc.","nameEN":"Tarsus Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tarsus Pharmaceuticals, Inc.(TARS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tarsus Pharmaceuticals, Inc.,TARS,Tarsus Pharmaceuticals, Inc.股票,Tarsus Pharmaceuticals, Inc.股票老虎,Tarsus Pharmaceuticals, Inc.股票老虎国际,Tarsus Pharmaceuticals, Inc.行情,Tarsus Pharmaceuticals, Inc.股票行情,Tarsus Pharmaceuticals, Inc.股价,Tarsus Pharmaceuticals, Inc.股市,Tarsus Pharmaceuticals, Inc.股票价格,Tarsus Pharmaceuticals, Inc.股票交易,Tarsus Pharmaceuticals, Inc.股票购买,Tarsus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tarsus Pharmaceuticals, Inc.(TARS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}